Immunoprecipitation of tyrosine-phosphorylated proteins followed by immunoblotting using anti-EphB4 showed high expression of EphB4 in 7/13 of the PDX samples (Figure 4B—Middle panel), indicating EphB4 hyperphosphorylation in pancreatic cancer. Here, EPHB4 is linked to pancreatic neoplasm.